Collateral damage: the impact on cancer outcomes of the COVID-19 pandemic
View ORCID ProfileAmit Sud, Michael Jones, View ORCID ProfileJohn Broggio, View ORCID ProfileChey Loveday, Bethany Torr, View ORCID ProfileAlice Garrett, David L. Nicol, View ORCID ProfileShaman Jhanji, Stephen A. Boyce, Phillip Ward, Jonathan M. Handy, Nadia Yousaf, James Larkin, Yae-Eun Suh, Stephen Scott, View ORCID ProfilePaul D.P. Pharoah, View ORCID ProfileCharles Swanton, Christopher Abbosh, Matthew Williams, Georgios Lyratzopoulos, View ORCID ProfileRichard Houlston, Clare Turnbull
doi: https://doi.org/10.1101/2020.04.21.20073833
Amit Sud
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
Michael Jones
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
John Broggio
2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
Chey Loveday
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
Bethany Torr
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
Alice Garrett
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
David L. Nicol
3Urology Unit, Royal Marsden NHS Foundation Trust, London, UK
Shaman Jhanji
4Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London, UK
5Division of Cancer Biology, Institute of Cancer Research, London, UK
Stephen A. Boyce
6Department of Colorectal Surgery, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
Phillip Ward
4Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London, UK
Jonathan M. Handy
4Department of Anaesthesia, Perioperative Medicine and Critical Care, Royal Marsden NHS Foundation Trust, London, UK
Nadia Yousaf
7Lung Cancer Unit, Royal Marsden NHS Foundation Trust, London, UK
James Larkin
8Skin and Renal Unit, Royal Marsden NHS Foundation Trust, London, UK
9Division of Clinical Studies, Institute of Cancer Research, London, UK
Yae-Eun Suh
10Department of Clinical Oncology, Royal Marsden NHS Foundation Trust, London, UK
Stephen Scott
11RM Partners, West London Cancer Alliance, Royal Marsden NHS Foundation Trust, London, UK
Paul D.P. Pharoah
12Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Charles Swanton
13Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK
14Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK
Christopher Abbosh
13Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK
14Cancer Evolution and Genome Instability Laboratory, University College London Cancer Institute, London, UK
Matthew Williams
15Department of Clinical Oncology, Imperial College Healthcare NHS Trust, London, UK
16Computational Oncology Group, Imperial College London, London, UK
Georgios Lyratzopoulos
2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
17Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group, University College London, London, UK
Richard Houlston
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
18Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK
Clare Turnbull
1Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK
2National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, UK
18Department of Clinical Genetics, Royal Marsden NHS Foundation Trust, London, UK
Posted April 29, 2020.
Collateral damage: the impact on cancer outcomes of the COVID-19 pandemic
Amit Sud, Michael Jones, John Broggio, Chey Loveday, Bethany Torr, Alice Garrett, David L. Nicol, Shaman Jhanji, Stephen A. Boyce, Phillip Ward, Jonathan M. Handy, Nadia Yousaf, James Larkin, Yae-Eun Suh, Stephen Scott, Paul D.P. Pharoah, Charles Swanton, Christopher Abbosh, Matthew Williams, Georgios Lyratzopoulos, Richard Houlston, Clare Turnbull
medRxiv 2020.04.21.20073833; doi: https://doi.org/10.1101/2020.04.21.20073833
Collateral damage: the impact on cancer outcomes of the COVID-19 pandemic
Amit Sud, Michael Jones, John Broggio, Chey Loveday, Bethany Torr, Alice Garrett, David L. Nicol, Shaman Jhanji, Stephen A. Boyce, Phillip Ward, Jonathan M. Handy, Nadia Yousaf, James Larkin, Yae-Eun Suh, Stephen Scott, Paul D.P. Pharoah, Charles Swanton, Christopher Abbosh, Matthew Williams, Georgios Lyratzopoulos, Richard Houlston, Clare Turnbull
medRxiv 2020.04.21.20073833; doi: https://doi.org/10.1101/2020.04.21.20073833
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (714)
- Anesthesia (209)
- Cardiovascular Medicine (2989)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12860)
- Forensic Medicine (12)
- Gastroenterology (839)
- Genetic and Genomic Medicine (4664)
- Geriatric Medicine (428)
- Health Economics (735)
- Health Informatics (2963)
- Health Policy (1078)
- Hematology (394)
- HIV/AIDS (940)
- Medical Education (432)
- Medical Ethics (116)
- Nephrology (478)
- Neurology (4448)
- Nursing (239)
- Nutrition (653)
- Oncology (2313)
- Ophthalmology (657)
- Orthopedics (260)
- Otolaryngology (329)
- Pain Medicine (286)
- Palliative Medicine (85)
- Pathology (504)
- Pediatrics (1205)
- Primary Care Research (506)
- Public and Global Health (7044)
- Radiology and Imaging (1561)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (388)
- Surgery (495)
- Toxicology (60)
- Transplantation (213)
- Urology (186)